
Iopromide
CAS No. 73334-07-3
Iopromide( Ultravist )
Catalog No. M15809 CAS No. 73334-07-3
Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 39 | In Stock |
![]() ![]() |
10MG | 55 | In Stock |
![]() ![]() |
25MG | 87 | In Stock |
![]() ![]() |
50MG | 129 | In Stock |
![]() ![]() |
100MG | 177 | In Stock |
![]() ![]() |
200MG | 266 | In Stock |
![]() ![]() |
500MG | 441 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameIopromide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare.
-
DescriptionIopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use.(In Vivo):Contrast medium-induced nephropathy can be induced by tail intravenous administration of iopromide. In randomized controlled trials, the global image quality and diagnostic quality with iobitridol does not differ from those with other low-osmolar contrast media (iohexol, iopromide, iopamidol, iomeprol and ioxaglate) or the iso-osmolar contrast medium iodixanol in adults or children undergoing radiographic imaging. Large post-marketing surveillance studies have confirmed that iobitridol produces good or excellent opacification and is an effective contrast agent in the vast majority of patients. Iobitridol is generally well tolerated and had a tolerability profile similar to that of other low-osmolar and iso-osmolar contrast media. Thus, iobitridol is an effective intravascular agent for contrast enhancement in diagnostic imaging.
-
In Vitro——
-
In VivoContrast medium-induced nephropathy can be induced by tail intravenous administration of iopromide. In randomized controlled trials, the global image quality and diagnostic quality with iobitridol does not differ from those with other low-osmolar contrast media (iohexol, iopromide, iopamidol, iomeprol and ioxaglate) or the iso-osmolar contrast medium iodixanol in adults or children undergoing radiographic imaging. Large post-marketing surveillance studies have confirmed that iobitridol produces good or excellent opacification and is an effective contrast agent in the vast majority of patients. Iobitridol is generally well tolerated and had a tolerability profile similar to that of other low-osmolar and iso-osmolar contrast media. Thus, iobitridol is an effective intravascular agent for contrast enhancement in diagnostic imaging.
-
SynonymsUltravist
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number73334-07-3
-
Formula Weight791.12
-
Molecular FormulaC18H24I3N3O8
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESc1(c(c(c(I)c(c1I)NC(COC)=O)C(NC[C@@H](CO)O)=O)I)C(N(C[C@@H](CO)O)C)=O
-
Chemical Name1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Palkowitsch PK, et al. Acta Radiol. 2014 Jul;55(6):707-14.
molnova catalog



related products
-
Vesatolimod
GS-9620 is an effective and specific orally active agonist of Toll-like receptor 7.
-
FUBP1-IN-1
FUBP1 - in-1, with an IC50 value of 11.0 M, is an effective FUSE binding protein 1 (FUBP1) inhibitor that can interfere with the binding of FUBP1 to its SINGLE-strand target DNA FUSE sequence.
-
Esculentoside A
Esculentoside A can suppress inflammatory responses in LPS-induced ALI through inhibition of the NF-κB and mitogen-activated protein kinase signaling pathways.